South Korea-based Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has signed a multi-year contract with Abu Dhabi Health Services Company (SEHA), the UAE's largest and most comprehensive healthcare network and a key pillar of the country's public healthcare system.
Under the five-year agreement, Lunit INSIGHT MMG, the company's AI solution for mammography analysis, will be deployed across SEHA's network of 14 hospitals and more than 70 primary healthcare and ambulatory care clinics, which together comprise over 3,000 beds.
This agreement follows a successful proof-of-concept (PoC) evaluation that Lunit and SEHA initiated in 2022. As part of that initial collaboration, SEHA assessed the performance of Lunit INSIGHT MMG, yielding promising results that led to this full-scale deployment. Over the next five years, Lunit INSIGHT MMG is expected to analyse more than a hundred thousand mammography images, supporting SEHA in enhancing breast cancer screening across the UAE.
The medical AI market in the Middle East is on a steep growth curve. From roughly $200 million in 2024, it is projected to grow to around $1–1.5 billion in the next 5–7 years. Specifically, the AI in healthcare market in the UAE is expected to reach $137.9 million by 2030, with a projected CAGR of 34.6%. The increasing adoption of AI-driven imaging solutions is expected to play a significant role in shaping the future of radiology in the region.
